Cargando…
In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
Clostridioides difficile infections (CDIs) are an urgent public health threat worldwide and are a leading cause of morbidity and mortality in healthcare settings. The increasing incidence and severity of infections combined with the scarcity of effective anti-CDI agents has made treatment of CDI ver...
Autores principales: | Abutaleb, Nader S., Seleem, Mohamed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007812/ https://www.ncbi.nlm.nih.gov/pubmed/33782498 http://dx.doi.org/10.1038/s41598-021-86595-3 |
Ejemplares similares
-
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2020) -
Auranofin Rapidly Eradicates Methicillin-resistant Staphylococcus aureus (MRSA) in an Infected Pressure Ulcer Mouse Model
por: Mohammad, Haroon, et al.
Publicado: (2020) -
Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection
por: Elhassanny, Ahmed E. M., et al.
Publicado: (2022) -
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018) -
Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs
por: Mohammad, Haroon, et al.
Publicado: (2021)